Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-053224
Filing Date
2023-04-28
Accepted
2023-04-28 18:00:34
Documents
1
Period of Report
2023-04-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2313909-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2313909-1_4seq1.xml 4 6324
  Complete submission text file 0001104659-23-053224.txt   7735
Mailing Address IROQUOIS CAPITAL MANAGEMENT LLC 205 EAST 42ND ST - 20TH FL. NEW YORK NY 10017
Business Address
Silverman Joshua (Reporting) CIK: 0001524858 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39752 | Film No.: 23868915

Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Issuer) CIK: 0001815903 (see all company filings)

EIN.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations